Tag: hormone receptor-positive breast cancer

In a groundbreaking development that may transform therapeutic strategies for hormone receptor-positive (HR⁺) breast cancer, new research reveals that fasting ...

In a groundbreaking revelation that could reshape therapeutic approaches to early breast cancer, the NeoRHEA phase 2 study unveils critical ...

In a groundbreaking advancement for breast cancer treatment, recent findings from the phase 3 monarchE trial have revealed that the ...

Brain metastases represent one of the most daunting complications encountered in breast cancer management, notoriously linked with dismal prognoses and ...

Researchers unveil a groundbreaking immune-based genomic signature that promises to revolutionize treatment strategies for hormone receptor-positive, HER2-negative breast cancer by ...

In the rapidly evolving field of cancer genomics, long non-coding RNAs (lncRNAs) have become a focal point of research due ...

Metformin, a drug primarily prescribed to manage type 2 diabetes, has increasingly captured the attention of oncologists and cancer researchers ...

In a groundbreaking development in the treatment of hormone receptor-positive breast cancer, recent findings have revealed that the novel PROTAC-based ...

In a groundbreaking study published in BMC Cancer, researchers have unveiled pivotal molecular distinctions between estrogen receptor-positive/progesterone receptor-positive (ER+/PR+) and ...

In a groundbreaking study poised to redefine our understanding of hormone receptor-positive (HR⁺) breast cancer development, researchers have shed new ...